A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Recruiting now

Conditions studied: Asthma

In brief

The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.

Key facts

Study ID

NCT07556159

Run by

Sanofi

People needed

2500

Starts

2026-04-01

Expected to finish

2029-04-04

Last updated by the study team

2026-07-24

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Applicable for Part 1 participants:
• Age 6 years and older, at the time of signing the informed consent
• Physician diagnosis of asthma for at least 12 months
• Existing treatment with low, medium, or high dose ICS and other asthma therapies as reflected in GINA 2-5 steps
• Participant or legally authorized representative (where applicable) has consented to participate
• Applicable for Part 2 participants:
• Age 18 years and older, at the time of signing the informed consent.
• Physician diagnosis of asthma for at least 12 months
• Existing treatment with low or medium ICS and other asthma therapies as reflected in GINA 2-4 steps
• Participant or legally authorized representative (where applicable) has consented to participate
• Participants must meet the criteria for at least one of the cohorts below:
• A) Asthma control cohorts
• ACQ-5 >= 1.5
• ACQ-5 < 1.5 (B) Type-2 biomarker cohorts
• Elevated T2 biomarkers (B1: Type-2-high cohort)
• Low T2 biomarkers (B2: Type-2-low cohort)
• Participants are excluded from the study if any of the following criteria apply (applicable for both Part 1 and Part 2 participants):
• Current diagnosis of chronic obstructive pulmonary disease (COPD) or congestive heart failure
• Participants with moderate/severe cognitive impairment.
• Participants with moderate/severe cardiac disease.
• Participants on immunosuppressive medication for a chronic condition.
• Participation in other interventional and noninterventional clinical study (currently or in the past 3 months)
• The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Where it is running

• Del Sol Research Management, LLC - Mesa - Site Number: 840123 — Mesa, Arizona, United States (enrolling)
• Sun City Clinical Trials - Elite - Site Number: 840120 — Sun City, Arizona, United States (enrolling)
• FOMAT - Huntington Asthma & Allergy Center - Site Number: 840158 — California City, California, United States (enrolling)
• Imax Clinical Trials - Site Number: 840109 — La Palma, California, United States (enrolling)
• Newport Native MD, Inc. - Site Number: 840101 — Newport Beach, California, United States (enrolling)
• Pasadena Clinical Trials - Site Number: 840116 — Pasadena, California, United States (enrolling)
• Valiance Clinical Research (JPJ Research) - Site Number: 840135 — Tarzana, California, United States (enrolling)
• Clinical Research of California - Site Number: 840145 — Walnut Creek, California, United States (enrolling)
• Cornerstone Research Institute, LLC - Site Number: 840152 — Altamonte Springs, Florida, United States (enrolling)
• 3SYNC Research - Boca Raton - Site Number: 840148 — Boca Raton, Florida, United States (enrolling)
• Meris Clinical Research - Site Number: 840167 — Brandon, Florida, United States (enrolling)
• Finlay Medical Research - Site Number: 840107 — Greenacres City, Florida, United States (enrolling)
• EMDA Clinical Research - Site Number: 840113 — Miami, Florida, United States (enrolling)
• Finlay Medical Research - Miami - Site Number: 840110 — Miami, Florida, United States (enrolling)
• Care Research Inc. - Site Number: 840103 — Miami, Florida, United States (enrolling)
• L&A Morales Healthcare, Inc - Site Number: 840102 — Miami, Florida, United States (enrolling)
• D&H National Research Centers INC - Site Number: 840128 — Miami, Florida, United States (enrolling)
• Research Institute Of South Florida - Site Number: 840149 — Miami, Florida, United States (enrolling)
• Valencia Medical & Research Center, Corp - Site Number: 840153 — Miami, Florida, United States (enrolling)
• Correa Research Center, Inc. - Site Number: 840141 — Miami, Florida, United States (enrolling)
• 3SYNC Research - Miami Lakes - Site Number: 840146 — Miami Lakes, Florida, United States (enrolling)
• Deluxe Health Center - Site Number: 840117 — Miami Lakes, Florida, United States (enrolling)
• MedQuest Translation Sciences, LLC - Site Number: 840162 — Miami Lakes, Florida, United States (enrolling)
• Biscayne Clinical Research - Site Number: 840157 — North Miami Beach, Florida, United States (enrolling)
• Chandler Clinical Trials - Site Number: 840106 — Chandler, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.